Intrinsic Value of S&P & Nasdaq Contact Us

Organigram Global Inc. OGI NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
39/100
2/7 Pass
SharesGrow Intrinsic Value
$7.93
+454.5%

Organigram Global Inc. (OGI) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 2 Buy, 2 Hold, 1 Sell.

Analysts estimate Earnings Per Share (EPS) of $-0.42 and revenue of $0.16B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.48 vs est $-0.42 (missed -13.8%). 2025: actual $-0.14 vs est $0.08 (missed -269.2%). Analyst accuracy: 14%.

OGI Analyst Ratings

Buy
5
Ratings
2 Buy
2 Hold
1 Sell
Based on 5 analysts giving stock ratings to Organigram Global Inc. in the past 3 months
Rating breakdown
Buy
2 40%
Hold
2 40%
Sell
1 20%
40%
Buy
2 analysts
40%
Hold
2 analysts
20%
Sell
1 analysts

EPS Estimates — OGI

14%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.48 vs Est –$0.42 ▼ 12.1% off
2025 Actual –$0.14 vs Est $0.08 ▼ 159.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — OGI

82%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.160B vs Est $0.160B ▼ 0.2% off
2025 Actual $0.186B vs Est $0.252B ▼ 35.7% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message